• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylhydrazines

Introduction to (3-(Trifluoromethoxy)phenyl)hydrazine Hydrochloride (CAS No. 133115-55-6)

(3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride is a specialized chemical compound with the CAS number 133115-55-6. This compound has garnered significant attention in the field of pharmaceutical and medicinal chemistry due to its unique structural properties and potential applications in drug development. The presence of a trifluoromethoxy group and a hydrazine moiety makes it a versatile intermediate in synthesizing various bioactive molecules.

The compound's molecular structure, characterized by a benzene ring substituted with a trifluoromethoxy group at the 3-position and a hydrazine moiety, contributes to its reactivity and functionality. This arrangement allows for further chemical modifications, making it a valuable building block in the synthesis of more complex molecules. The hydrochloride salt form enhances its solubility in polar solvents, facilitating its use in various biochemical assays and pharmaceutical formulations.

In recent years, there has been growing interest in exploring the pharmacological properties of (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride. Researchers have been investigating its potential as an intermediate in the synthesis of novel therapeutic agents. The trifluoromethoxy group is known to influence the metabolic stability and binding affinity of molecules, making it a crucial feature for drug design. Additionally, the hydrazine moiety can participate in various chemical reactions, including condensation reactions with carbonyl compounds, which is essential for constructing heterocyclic structures.

One of the most promising areas of research involving (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride is its application in anticancer drug development. Studies have shown that hydrazine derivatives can exhibit inhibitory effects on certain enzymes involved in tumor growth and progression. The introduction of a trifluoromethoxy group into these derivatives can enhance their bioavailability and therapeutic efficacy. For instance, researchers have synthesized analogs of (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride and evaluated their cytotoxicity against various cancer cell lines. Preliminary results indicate that these compounds demonstrate significant anti-proliferative activity, suggesting their potential as lead candidates for further drug development.

Another area of interest is the use of (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride in the development of antimicrobial agents. The unique structural features of this compound allow it to interact with bacterial enzymes and disrupt essential metabolic pathways. Recent studies have focused on its ability to inhibit bacterial growth by targeting key enzymes involved in DNA replication and protein synthesis. The trifluoromethoxy group enhances the compound's ability to penetrate bacterial cell membranes, improving its efficacy as an antimicrobial agent. This has opened up new avenues for developing novel antibiotics to combat antibiotic-resistant strains.

The synthesis of (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride involves multi-step organic reactions, requiring precise control over reaction conditions to ensure high yield and purity. The process typically begins with the functionalization of a benzene ring to introduce the trifluoromethoxy group, followed by the addition of a hydrazine moiety. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to achieve higher selectivity and efficiency in these transformations.

In conclusion, (3-(Trifluoromethoxy)phenyl)hydrazine hydrochloride is a versatile compound with significant potential in pharmaceutical research and drug development. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules with applications in anticancer and antimicrobial therapies. Ongoing research continues to explore its pharmacological properties and optimize synthetic methodologies for large-scale production. As our understanding of its biological activities grows, so does its importance in the field of medicinal chemistry.

• 647855-19-4(Benzenamine, 4-methoxy-3-(trifluoromethoxy)-, hydrochloride)
• 62128-84-1(4-(Difluoromethoxy)phenylhydrazine)
• 13957-54-5([4-(trifluoromethoxy)phenyl]hydrazine)
• 461-82-5(4-(Trifluoromethoxy)aniline)
• 133115-72-7([4-(trifluoromethoxy)phenyl]hydrazine hydrochloride)
• 62128-83-0(3-(difluoromethoxy)phenylhydrazine)
• 791029-98-6(1-(2-(Trifluoromethoxy)phenyl)hydrazine)
• 1535-73-5(3-(Trifluoromethoxy)aniline)
• 650628-49-2(1-(3-(Trifluoromethoxy)phenyl)hydrazine)
• 42823-24-5(4-(Trifluoromethoxy)aniline hydrochloride)